Contrast Injector Market Size, Share, Growth Report 2030

Contrast Injector Market

Contrast Injector Market By Product (Injector Systems, Consumables, and Accessories) and By Application (Radiology, Interventional Cardiology, Interventional Radiology): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Category: Medical Device Report Format : PDF Pages: 130 Report Code: ZMR-2086 Published Date: May-2021 Status : Published

The global contrast injector market accounted for USD 765 Million in 2020 and is expected to reach USD 1,447 Million by 2028, growing at a CAGR of 8.2% from 2021 to 2028.

Market Overview

The global contrast injector market accounted for USD 765 Million in 2020 and is expected to reach USD 1,447 Million by 2028, growing at a CAGR of 8.2% from 2021 to 2028.

Contrast dye or agent is a chemical substance that is used for increasing contrast of fluids in the human body during medical imaging. Contrast agents are used for improving radio density during a medical imaging scan of a tissue or an organ. There are various types of contrast agents used for improving visibility of gastrointestinal tract and vessels. In X-rays, the most commonly used contrast agents are iodine and barium and during magnetic resonance imaging scans, gadolinium is utilized as an MRI contrast agent.

Contrast injector are used for injecting contrast agent in human body during a radiography scan. These contrast injectors help in monitoring contrast dosage, recording quantity of contract agent used, detecting potential health hazards during scan, and increasing dosage speed during tests. Contrast injectors play a crucial role in ensuring patient safety and imaging quality.

Request Free Sample

COVID-19 Impact Analysis

The global contrast injector market growth has witnessed a decrease during COVID-19 crisis as there has been decrease in the number of new imaging labs opened in around the world owing to trade restrictions and lockdown enforcement imposed by governments. Many hospitals and diagnostic centers have limited scanning as there is risk for COVID virus transmission. Trade restrictions among countries and continents have also affected production and have resulted in supply chain disruption in medical industry. This factor is likely to hamper the contrast injector market growth. However, there has been significant increase in the number of CT scans done during COVID-19 pandemic as CT scans can be useful in diagnosing COVID-19 infection among critically ill patients for suspicion of infection. This rise in the number of CT tests done is anticipated to trigger market growth.

Growth Factors

Growing healthcare industry around the world has accelerated the number of diagnosis done for detecting various disorders in humans. This rise in the number of tests has also been bolstered by increasing number of individuals suffering from cancer, brain disorders, spinal diseases, and physical injuries. Such growth in the number of  tests done is likely to boost the demand for contrast agents in medical diagnostic industry, which may also fuel the demand for contrast injectors.

There has been significant increase in investment from municipal and federal authorities in developing and expanding healthcare infrastructure in urban as well as rural areas of the world. This increase in investment in healthcare industry is expected to increase the number of new diagnostic centers in developing as well as developed parts of the world. This anticipated rise in the number of diagnostic centers should boost the demand for new contrast injectors. Further, there has also been growth in the number of imaging centers for treating various chronic disorders which should also contribute to the growth of the contrast injectors market globally.

Report Scope:

Request Free Sample

Product Segment Analysis Preview

In terms of products, the consumables segment dominated the global contrast injectors market in 2020. Consumables such as injector heads, syringes, and tubes hold an important position in imaging test as these ensure efficient contrast dosage and scan quality. Also, there has been significant growth in the demand for high quality consumables to ensure effective imaging scan results. This trend may also accelerate the market growth.

Injector systems segment is estimated to grow at a highest growth rate owing to growing number of diagnostic centers worldwide. Contrast injectors systems are used in imaging scans like CT, MRI, and angiography. In recent years there has been a significant rise in the number of individuals suffering from cardiovascular disorders, which has propelled the angiography scan demand worldwide. Such a ride should contribute the demand for contrast injector consumables.  

Request Free Sample

Application Segment Analysis Preview

Based on applications, the radiology segment dominated the global market, accounting for a market share of approximately 50% in 2020. Various types of imaging technologies such as computed tomography (CT), positron emission tomography (PET), and magnetic resonance imaging (MRI) are used by radiologists for diagnosing different types of chronic diseases such as blood clots, thrombosis, cancer, and tumor. These technologies use contrast injectors for effective scans and avoiding health hazards to patients. Such use of contrast injectors should proliferate the contrast injectors market growth for radiology applications.

Regional Analysis Preview

Asia Pacific is expected to grow at the fastest rate in years ahead pertaining to soaring growth in the healthcare and medical sector in the region. Changing lifestyle and eating patterns have accelerated the prevalence of various chronic diseases such as diabetes, heart disorders, and cancers. Such rise in the number of individuals suffering from chronic diseases has fueled the imaging scan market in Asia Pacific, which has led to an increase in the number of new diagnostic centers in the region. This is likely to proliferate the Asia Pacific contrast injectors market.

Request Free Sample

North American region held a major share in the global contrast injectors market, constituting a market share of around 35% in 2020. Existing developed and established healthcare system in countries like the United States and Canada has boosted adoption of advanced imaging technologies. Such adoption of advanced technologies should contribute to the growth of the contrast injector market growth.

Key Market Players & Competitive Landscape

Some of the key players in contrast injector market are Bayer HealthCare, GE Healthcare, Bracco Imaging S.p.A., AngioDynamics, Medtron AG, ulrich GmbH & Co. KG, Guerbet Group, VIVID IMAGING , Sino Medical Device Technology Co., Ltd., Apollo RT Co., Ltd., and Nemoto Kyorindo Co., Ltd.

The global Contrast Injector market is segmented as follows:

By Product

  • Injector Systems,
  • Consumables
  • Accessories

By Application

  • Radiology
  • Interventional Cardiology
  • Interventional Radiology

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

Free Analysis

FrequentlyAsked Questions

The global Contrast Injector market was valued at USD 765 Million in 2020.

The global contrast injector market is expected to reach USD 1,447 Million by 2028, growing at a CAGR of 8.2% from 2021 to 2028.

Growing healthcare industry around the world has accelerated the number of diagnosis done for detecting various disorders in humans. This rise in the number of tests has also been bolstered by increasing number of individuals suffering from cancer, brain disorders, spinal diseases, and physical injuries. Such growth in the number of  tests done is likely to boost the demand for contrast agents in medical diagnostic industry, which may also fuel the demand for contrast injectors.

North American region held a major share in the global contrast injectors market, constituting a market share of around 35% in 2020. Existing developed and established healthcare system in countries like United States and Canada has boosted adoption of advanced imaging technologies. Such adoption of advanced technologies should contribute to the growth of the contrast injector market growth.

Some of key players in contrast injector market are Bayer HealthCare, GE Healthcare, Bracco Imaging S.p.A., AngioDynamics, Medtron AG, ulrich GmbH & Co. KG, Guerbet Group, VIVID IMAGING , Sino Medical Device Technology Co., Ltd., Apollo RT Co., Ltd., and Nemoto Kyorindo Co., Ltd.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed